Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
Phase of Trial: Phase IV
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Aztreonam (Primary)
- Indications Bronchiolitis obliterans
- Focus Therapeutic Use
- 25 Nov 2015 Safety study has been removed from primary endpoints as reported by ClinicalTrials.gov.
- 23 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.